18F flutemetamol amyloid-beta PET imaging compared with 11CPIB across the spectrum of Alzheimer's disease
Not Applicable
- Conditions
- Alzheimer's disease
- Registration Number
- JPRN-UMIN000019573
- Lead Sponsor
- Shonan-Atsugi hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
AD subjects were older than 56 years, and met the core clinical criteria of the NIA-Alzheimer's Association for probable AD. MCI subjects were older than 56 years, and met the Core Clinical Criteria for MCI proposed by the NIA-Alzheimer's Association. The normal cognitive status of HC subjects was required to be a MMSE score of 28 or greater and a CDR score of 0. All subjects or their caregiver provided written informed consent for participation. Participants were excluded if they had other systemic or brain diseases,including degenerative,vascular, depressive, traumatic, medical comorbidities, mixed disease, or traumatic brain injury.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method